← back to search

Iván Martín

University of Aberdeen · GB
Area of research
Rheumatology · Genetics
Research interest
Research focused on Mesenchymal stem cell and Clinical trial, with related work in In vivo, Stromal cell, Cell therapy. Notable publications include 'Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature', 'International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials', and 'Limited Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stromal Cells'.
h-index
citations
1,716
works
11
NIH funding
primary concept
email

Recent publications

An International Society for Cell and Gene Therapy Mesenchymal Stromal Cells (MSC) Committee perspectives on International Standards Organization/Technical Committee 276 Biobanking Standards for bone marrow-MSCs and umbilical cord tissue–derived MSCs for research purposes
Cytotherapy 2023cited by 24position: lastdoi
Intervertebral Disc-on-a-Chip as Advanced In Vitro Model for Mechanobiology Research and Drug Testing: A Review and Perspective
Frontiers in Bioengineering and Biotechnology 2022cited by 20position: middledoi
Mesenchymal stromal cell variables influencing clinical potency: the impact of viability, fitness, route of administration and host predisposition
Cytotherapy 2021cited by 65position: lastdoi
Cell-based therapies for coronavirus disease 2019: proper clinical investigations are essential
Cytotherapy 2020cited by 45position: middledoi
Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature
Cytotherapy 2019cited by 812position: middledoi
Bone Research Society Abstracts
JBMR Plus 2018cited by 2position: middledoi
Spontaneous In Vivo Chondrogenesis of Bone Marrow-Derived Mesenchymal Progenitor Cells by Blocking Vascular Endothelial Growth Factor Signaling
Stem Cells Translational Medicine 2016cited by 51position: lastdoi
International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials
Cytotherapy 2015cited by 510position: middledoi
Scaffold-Based Delivery of a Clinically Relevant Anti-Angiogenic Drug Promotes the Formation of <i>In Vivo</i> Stable Cartilage
Tissue Engineering Part A 2013cited by 53position: middledoi
MSCs: science and trials
Nature Medicine 2013cited by 41position: middledoi
Limited Acquisition of Chromosomal Aberrations in Human Adult Mesenchymal Stromal Cells
Cell stem cell 2012cited by 93position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 7 papers (2012–2023)Jacques Galipeau · University of Wisconsin–Madison7 papers (2012–2023)Donald G. Phinney · Scripps Institution of Oceanography6 papers (2012–2021)Yufang Shi · University of Rome Tor Vergata6 papers (2012–2023)Sowmya Viswanathan · University Health Network5 papers (2015–2023)Jan A. Nolta · University of California, Davis4 papers (2019–2023)Katarina LeBlanc · Stockholm County Council4 papers (2015–2021) · 4 papers (2012–2019)Karin Tarte · Université Bretagne Loire3 papers (2012–2023) · 3 papers (2013–2022)Matteo Centola · Università Campus Bio-Medico2 papers (2013–2016)Anna Marsano · Columbia University2 papers (2013–2016)Mike Barbeck · University of Rostock1 papers (2016–2016)Roman Tsaryk · Johannes Gutenberg University Mainz1 papers (2016–2016)Michael Mendicino · Case Western Reserve University1 papers (2015–2015)Patrícia R. M. Rocco · University of Vermont1 papers (2020–2020)Shahram Ghanaati · Goethe University Frankfurt1 papers (2016–2016)J. M. Gimble · Tulane University1 papers (2015–2015)Robert Deans · Case Western Reserve University1 papers (2015–2015)Ian McNiece · University of Nebraska Medical Center1 papers (2015–2015)